Tango Therapeutics (TNGX) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Tango Therapeutics (TNGX) Company Statistics | The Fly

Tango Therapeutics

· TNGX

Dashboard

Financials

Ratios

Valuation

Statistics

4.117 B

+2.17%

General

Market Cap: $4.12B
Enterprise Value: $3.75B
Shares Outstanding: 162,330,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 98.25%
Operating Margin: -253.38%
Net Profit Margin: -229.92%
FCF Margin: -268.10%
ROA: -11.52%
ROE: -25.74%
ROIC: -12.90%
Current Ratio: 50.82
Debt-to-Equity: 0.03
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 75.49
P/FCF: —
P/B: 3.96
EV/EBITDA: -30.65

Growth

Rev 1Y: 48.29%
Rev 1Y Fwd Est: -90.29%
Rev 3Y (CAGR): 35.89%
Rev 5Y (CAGR): 52.13%
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —

Income Statement (TTM)

Revenue: $53.81M
Gross Margin: 98.25%
Operating Expenses: $189.22M
Operating Income: -$136.35M
Net Profit: -$123.72M

Balance Sheet

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $345.56M
Working Capital: $1.01B
Total Assets: $1.07B
Net Debt: -$313.57M
Total Liabilities: $49.35M
Total Equity: $1.02B

Cash Flow Statement (TTM)

Cash Flow from Operations: -$143.9M
Cash Flow from Investing: -$524.58M
Cash Flow from Financing: $974.33M
Free Cash Flow: -$144.27M
Capital Expenditures: $373K